Home » Newsletters » BioWorld

BioWorld

Aug. 22, 2003

View Archived Issues

IPOs On The Rise: Nitromed, Pharmion, Acusphere On File

Three biotech companies recently have filed for initial public offerings in what appears to be a developing trend. (BioWorld Today) Read More

Cephalon's Hostile Takeover Bid For CIMA Ups The Ante

Two Human Immunities - Innate, Adaptive - Set Experimental Model To Mimic Multiple Sclerosis Course

Merck Options, Returns Aspects Of Vical's DNA Delivery Platform

BioStratum Opens Bridge Funding With $9.5M For Nephropathy Drug

CuraGen Subsidiary Sequences Whole Adenovirus In One Day

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...